pharmaceuticals

Stocks in focus: GAIL, Hindalco, Ashok Leyland, Coal India, Tata Steel, TCS, Emami, pharma stocks

Analysts expect the near-term trend of Nifty to remain positive and see more upside in the coming sessions.

RIL, bharti airtel

Nifty Pharma index nearly doubles since March; 3 pharma stocks set to rally up to 45% 

Macquaries sees Divi's Laboratories and Syngene International as well placed in terms of growth, margin profile and return ratios

Sensex, nifty,

This pharma share is up 175% since January, Macquarie says it’s still cheap; check upside, target price

After moving 175% higher since the beginning of this year when it traded at Rs 427 per share, to now at a 52-week high of Rs 1,245 apiece, Solara Active Pharma scrip has come a long way.

Huntington’s Disease Market to reach $2.6 Billion by 2024: GlobalData

The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the market landscape,’ says analyst

MindCraft Software appoints Amol Bavdekar as CEO

Hemant Nerurkar will continues to be as the chairman MindCraft Software, a global software products, solutions and services organisation catering to the banking, financial services and pharmaceuticals industries has appointed

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma companies can contest the ban On March 10, 2016, vide its notifications bearing S.O. 705(E) through S

Mapping post-marketing surveillance of pharmaceuticals in India

Ensuring safe and quality medicines requires continuous monitoring by regulators and manufacturers alike.

Tracking and tracing pharmaceuticals: The big picture

Track and trace technologies (T&T) are touted to be the game-changer in ensuring safe drug distribution chains and instituting quality and expiry recalls.

pharmaceutical industries

Experts address impact of M&A in pharma and promoting API manufacturing in India

M&A report recommendations focused on pricing, production and availability, R&D and social consequences In order to provide greater clarity on the policy governing M&A/FDI in the pharmaceutical sector, while strik

ISPE debuts drug shortage prevention tool at annual meeting

The tool will enable companies to address supply chain risks with a common framework, no matter their size, capability or location International Society for Pharmaceutical Engineering (ISPE) at its Annual Meeting in Philadelp

Jubilant Life Sciences posts Q2 & H1 FY2016 results

In Q2 FY16, the company’s consolidated revenue was at Rs 1,463 crore The board of Jubilant Life Sciences recently met to approve the financial results for the quarter ended September 30, 2015. In Q2 FY16, the company&#8

Hiring grew 13 per cent in Aug, to pick up further, says Naukri.Com

Pharma sector comes in the third position while hiring

Hiring grew 13 per cent in Aug, to pick up further, says Naukri.Com

Healthcare sector comes in the second position while hiring

Novartis India posts results for quarter ended June 30, 2015

The company registered net profit after other income of Rs 13.5 crore The Board of Novartis India approved the results for the quarter ended June 30, 2015. During the period under review, total income from operations was Rs 2

Indian Patent office issues new guidelines for pharmaceutical patent applications

Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure

Steered by HLL, GAPL expands operations in Goa

First GAPL Medicentre public pharmacy outlet inaugurated in Panaji

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Top News

Advertisement

Related Articles